Compare Novavax Inc (NVAX) vs Petróleo Brasileiro SA (PBR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Petróleo Brasileiro SA — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Petróleo Brasileiro SA trades at $18.51 (market cap $108.78B). The key difference: Petróleo Brasileiro SA is far larger — about 83.7× Novavax Inc's market cap, and Petróleo Brasileiro SA pays a 9.81% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | PBR | |
|---|---|---|
Market Cap | $1.30B | $108.78B |
Sector | Health | Technology |
52-Week High | $11.19 | $22.03 |
52-Week Low | $6.22 | $11.54 |
Enterprise Value | $800.50M | $171.32B |
Dividend Yield | — | 9.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Petróleo Brasileiro SA
Petróleo Brasileiro S.A., commonly known as Petrobras, is a state-controlled Brazilian multinational corporation in the oil and gas industry. The company is one of the world's largest producers of oil and gas, primarily operating in exploration, production, refining, and power generation. Petrobras is particularly known for its deep-sea and ultra-deep-sea exploration and production activities in the vast pre-salt offshore reserves, which are a major component of Brazil's economy.
Read more on PBR →
